Sign in
4

Changes in Ownership

TriSalus Life Sciences, Inc. Filed Acc 0001415889-25-004688

Chief Financial Officer acquired 14,762 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Young James Emmett Chief Financial Officer 2025-02-18 Grant or award +14,762 36,488 D
Loading xslF345X05/form4-02192025_100242.xml…